Case fatality risk of influenza a (H1N1pdm09): A systematic review

Epidemiology

Volumn 24, Issue 6, 2013, Pages 830-841

  Wong, Jessica Y ^a   Kelly, Heath ^b,c   Ip, Dennis K M ^a   Wu, Joseph T ^a   Leung, Gabriel M ^a   Cowling, Benjamin J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^c The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE FATALITY RISK; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MORTALITY; PANDEMIC INFLUENZA; POPULATION DISTRIBUTION; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; TAIWAN; VIRUS STRAIN;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; RISK; WORLD HEALTH;

EID: 84885386643     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3182a67448     Document Type: Article

References (74)

1. V an Kerkhove MD, Asikainen T, Becker NG, et al. Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: Insights from modeling. PLoS Med. 2010;7:e1000275
2. L ipsitch M, Hayden FG, Cowling BJ, Leung GM. How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet. 2009;374:1209-1211
3. Boëlle PY, Ansart S, Cori A, Valleron AJ. Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: A review. Influenza Other Respi Viruses. 2011;5:306-316
4. W orld Health Organization. Implementation of the International Health Regulations (2005): Report of the Review Committee on the Functioning of the International Health Regulations (2005) in relation to Pandemic (H1N1) 2009. Geneva: World Health Organization; 2011. Available at: Http://apps.who.int/gb/ ebwha/pdf-files/WHA64/A64-10-en.pdf. Accessed 14 February 2013
5. Nishiura H. Case fatality ratio of pandemic influenza. Lancet Infect Dis. 2010;10:443-444
6. W ong JY, Wu P, Nishiura H, et al. The infection fatality risk of pandemic influenza A(H1N1) in Hong Kong in 2009. Am J Epidemiol. 2013;177:834-840
7. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol. 2009;62:1006-1012
8. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558
9. Metafor. Meta-analysis package for R [computer program]. Version 1.6-0. 2011
10. Abdalla E, HabteMariam T, Nganwa D, et al. Epidemiology of influenza A 2009 H1N1 virus pandemic in the U.S. J Health Care Poor Underserved. 2011;22(suppl 4):39-60
11. Adhikari BR, Shakya G, Upadhyay BP, et al. Outbreak of pandemic influenza A/H1N1 2009 in Nepal. Virol J. 2011;8:133
12. Ahmed F, Al Hosani F, Al Mannaie A, Harrison O. Early outcomes of pandemic influenza (H1N1) 2009 surveillance in Abu Dhabi Emirate, May-August 2009. East Mediterr Health J. 2012;18:31-36
13. Baker MG, Wilson N, Huang QS, et al. Pandemic influenza A(H1N1)v in New Zealand: The experience from April to August 2009. Euro Surveill. 2009;14:19319
14. Balaganesakumar SR, Murhekar MV, Swamy KK, et al. Risk factors associated with death among influenza A (H1N1) patients, Tamil Nadu, India, 2010. J Postgrad Med. 2013;59:9-14
15. Bandaranayake D, Huang QS, Bissielo A, et al. Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One. 2010;5:e13211
16. Bandaranayake D, Jacobs M, Baker M, et al. The second wave of 2009 pandemic influenza A(H1N1) in New Zealand, January-October 2010. Euro Surveill. 2011;16:19788
17. Brooks-Pollock E, Tilston N, Edmunds WJ, et al. Using an online survey of healthcare-seeking behaviour to estimate the magnitude and severity of the 2009 H1N1v influenza epidemic in England. BMC Infect Dis. 2011;11:68
18. C astro-Jiménez MA, Castillo-Pabón JO, Rey-Benito GJ, et al.; Virology Group; Communicable Diseases Surveillance Group. Epidemiologic analysis of the laboratory-confirmed cases of influenza A(H1N1)v in Colombia. Euro Surveill. 2009;14:19284
19. C hen CJ, Lee PI, Chang SC, et al. Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan. PLoS One. 2011;6:e24440
20. C howell G, Echevarria-Zuno S, Viboud C, et al. Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med. 2011;8:e1000436
21. C utter JL, Ang LW, Lai FY, Subramony H, Ma S, James L. Outbreak of pandemic influenza A (H1N1-2009) in Singapore, May to September 2009. Ann Acad Med Singapore. 2010;39:273-210
22. Dawood FS, Hope KG, Durrheim DN, et al. Estimating the disease burden of pandemic (H1N1) 2009 virus infection in Hunter New England, Northern New South Wales, Australia, 2009. PLoS One. 2010;5:e9880
23. de Silva UC, Warachit J, Waicharoen S, Chittaganpitch M. A preliminary analysis of the epidemiology of influenza A(H1N1)v virus infection in Thailand from early outbreak data, June-July 2009. Euro Surveill. 2009;14:19292
24. Donaldson LJ, Rutter PD, Ellis BM, et al. Mortality from pandemic A/ H1N1 2009 influenza in England: Public health surveillance study. BMJ. 2009;339:b5213
25. Doshi SS, Stauffer KE, Parker Fiebelkorn A, et al. The burden and severity of illness due to 2009 pandemic influenza A (H1N1) in a large US city during the late summer and early fall of 2009. Am J Epidemiol. 2012;176:519-526
26. E chevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, et al. Infection and death from influenza A H1N1 virus in Mexico: A retrospective analysis. Lancet. 2009;374:2072-2079
27. Flahault A. First estimation of direct H1N1pdm virulence: From reported non consolidated data from Mauritius and New Caledonia. PLoS Curr. 2009;1:RRN1010
28. Fraser C, Donnelly CA, Cauchemez S, et al.; WHO Rapid Pandemic Assessment Collaboration. Pandemic potential of a strain of influenza A (H1N1): Early findings. Science. 2009;324:1557-1561
29. Garske T, Legrand J, Donnelly CA, et al. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ. 2009;339:b2840
30. Glinsky GV. Real-time case fatality analysis points to emerging evidence of increasing severity of pandemic (H1N1) 2009. Cell Cycle. 2009;8:3057-3062
31. Godoy P, Pumarola T, Martinez A, et al. Surveillance of the pandemic influenza (H1N1) 2009 in Catalonia: Results and implications. Rev Esp Salud Publica. 2011;85:37-45
32. Gomez J, Munayco C, Arrasco J, et al. Pandemic influenza in a southern hemisphere setting: The experience in Peru from May to September, 2009. Euro Surveill. 2009;14:19371
33. Gu Y, Shimada T, Yasui Y, et al. National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic. PLoS One. 2013;8:e54786
34. Hadler JL, Konty K, McVeigh KH, et al. Case fatality rates based on population estimates of influenza-like illness due to novel H1N1 influenza: New York City, May-June 2009. PLoS One. 2010;5:e11677
35. Kamigaki T, Oshitani H. Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan. PLoS Curr. 2009;1:RRN1139
36. Kim HS, Kim JH, Shin SY, et al. Fatal cases of 2009 pandemic influenza A (H1N1) in Korea. J Korean Med Sci. 2011;26:22-27
37. Kool JL, Pavlin BI, Musto J, et al. Influenza surveillance in the Pacific Island countries and territories during the 2009 pandemic: An observational study. BMC Infect Dis. 2013;13:6
38. L arrieu S, Rosine J, Ledrans M, et al. Epidemic of influenza A(H1N1) 2009 in the French overseas territories of the Americas: Epidemiological surveillance set up and main results, April 2009-January 2010. Bull Soc Pathol Exot. 2011;104:119-124
39. McVernon J, Laurie K, Nolan T, et al. Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October -December 2009. Euro Surveill. 2010;15:19678
40. Mishra AC, Chadha MS, Choudhary ML, et al. Pandemic influenza (H1N1) 2009 is associated with severe disease in India. PLoS One. 2010;5:e10540
41. Nishiura H, Klinkenberg D, Roberts M, Heesterbeek JA. Early epidemiological assessment of the virulence of emerging infectious diseases: A case study of an influenza pandemic. PLoS One. 2009;4:e6852
42. Nishiura H. The relationship between the cumulative numbers of cases and deaths reveals the confirmed case fatality ratio of a novel influenza A (H1N1) virus. Jpn J Infect Dis. 2010;63:154-156
43. Nishiura H. The virulence of pandemic influenza A (H1N1) 2009: An epidemiological perspective on the case-fatality ratio. Expert Rev Respir Med. 2010;4:329-338
44. Pebody RG, McLean E, Zhao H, et al. Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: Risk factors for death, April 2009 to March 2010. Euro Surveill. 2010;15:19571
45. Presanis AM, De Angelis D, Hagy A, et al.; New York City Swine Flu Investigation Team. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: A Bayesian analysis. PLoS Med. 2009;6:e1000207
46. Presanis AM, Pebody RG, Paterson BJ, et al. Changes in severity of 2009 pandemic A/H1N1 influenza in England: A Bayesian evidence synthesis. BMJ. 2011;343:d5408
47. Renault P, Thouillot F, Do C, et al. Epidemic of influenza A(H1N1) 2009 in Reunion Island: Epidemiological data. Bull Soc Pathol Exot. 2011;104:108-113
48. Riley S, Kwok KO, Wu KM, et al. Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med. 2011;8:e1000442
49. Sachedina N, Donaldson LJ. Paediatric mortality related to pandemic influenza A H1N1 infection in England: An observational population-based study. Lancet. 2010;376:1846-1852
50. Simon Mendez L, de Mateo Ontanon S, Larrauri Camara A, et al. Transmissibility and severity of the pandemic influenza A (H1N1) 2009 virus in Spain. Gac Sanit. 2011;25:296-302
51. Steens A, Waaijenborg S, Teunis PF, et al. Age-dependent patterns of infection and severity explaining the low impact of 2009 influenza A (H1N1): Evidence from serial serologic surveys in the Netherlands. Am J Epidemiol. 2011;174:1307-1315
52. Sypsa V, Bonovas S, Tsiodras S, et al. Estimating the disease burden of 2009 pandemic influenza A(H1N1) from surveillance and household surveys in Greece. PLoS One. 2011;6:e20593
53. T uite AR, Greer AL, Whelan M, et al. Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ. 2010;182:131-136
54. V aillant L, La Ruche G, Tarantola A, Barboza P; Epidemic Intelligence Team at InVS. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill. 2009;14:19309
55. Human infection with new influenza A (H1N1) virus: Clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec. 2009;84:185-189
56. W ilking H, Buda S, von der Lippe E, et al. Mortality of 2009 pandemic influenza A(H1N1) in Germany. Euro Surveill. 2010;15:19741
57. W ilson N, Baker MG. The emerging influenza pandemic: Estimating the case fatality ratio. Euro Surveill. 2009;14:19255
58. W u JT, Ma ES, Lee CK, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis. 2010;51:1184-1191
59. L essler J, Reich NG, Cummings DA, Nair HP, Jordan HT, Thompson N; New York City Department of Health and Mental Hygiene Swine Influenza Investigation Team. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med. 2009;361:2628-2636
60. Rudge JW, Hanvoravongchai P, Krumkamp R, et al.; AsiaFluCap Project Consortium. Health system resource gaps and associated mortality from pandemic influenza across six Asian territories. PLoS One. 2012;7:e31800
61. SteelFisher GK, Blendon RJ, Ward JR, et al. Public response to the 2009 influenza A H1N1 pandemic: A polling study in five countries. Lancet Infect Dis. 2012;12:845-850
62. Baguelin M, Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ. Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation. Vaccine. 2010;28:2370-2384
63. Kelly H, Peck HA, Laurie KL, et al. The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination. PLoS One. 2011;6:e21828
64. L au LL, Nishiura H, Kelly H, et al. Household transmission of 2009 pandemic influenza A (H1N1): A systematic review and meta-analysis. Epidemiology. 2012;23:531-542
65. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med. 2005;165:265-272
66. T hompson WW, Moore MR, Weintraub E, et al. Estimating influenza-associated deaths in the United States. Am J Public Health. 2009;99(suppl 2):S225-S230
67. Melegaro A, Jit M, Gay N, Zagheni E, Edmunds WJ. What types of contacts are important for the spread of infections?: Using contact survey data to explore European mixing patterns. Epidemics. 2011;3:143-151
68. Hollingsworth TD, Klinkenberg D, Heesterbeek H, Anderson RM. Mitigation strategies for pandemic influenza A: Balancing conflicting policy objectives. PLoS Comput Biol. 2011;7:e1001076
69. Ahmad OB, Boschi-Pinto C, Lopez AD. Age Standardization of Rates: A New WHO Standard. GPE Discussion Paper No. 31. Geneva: World Health Organisation; 2001
70. C howell G, Echevarria-Zuno S, Viboud C, et al. Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: Age shift and severity. PLoS Curr. 2012;4:RRN1306
71. V an Kerkhove MD, Vandemaele KA, Shinde V, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: A global pooled analysis. PLoS Med. 2011;8:e1001053
72. Zhang YH, Zhao Y, Li N, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun. 2013;4:1418
73. W u JT, Ho A, Ma ES, et al. Estimating infection attack rates and severity in real time during an influenza pandemic: Analysis of serial crosssectional serologic surveillance data. PLoS Med. 2011;8:e1001103
74. Dawood FS, Iuliano AD, Reed C, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study. Lancet Infect Dis. 2012;12:687-695